Literature DB >> 19222408

The influence of symptom type and duration on the fate of the metaplastic columnar-lined Barrett's oesophagus.

P A C Gatenby1, J R Ramus, C P J Caygill, R C Fitzgerald, A Charlett, M C Winslet, A Watson.   

Abstract

BACKGROUND: Prolonged gastro-oesophageal reflux resulting in columnar metaplasia of the oesophagus is the main risk factor for oesophageal adenocarcinoma. AIM: To examine the duration of symptoms and associations of different symptoms with the development of columnar-lined oesophagus, dysplasia and adenocarcinoma.
METHODS: UK multicentre cohort study of patients with columnar-lined oesophagus whose date of symptom onset (1082 patients) and/or types of symptoms reported (1681 patients) were documented. Follow-up was examined by analysis of histological reports from the registering centers.
RESULTS: Symptoms of dysphagia/odynophagia and nausea/vomiting were associated with development of dysplasia. High-grade dysplasia and adenocarcinoma were associated with dysphagia/odynophagia and weight loss. Median duration from symptom onset to detection of columnar-lined oesophagus without intestinal metaplasia: 2.6 years, columnar-lined oesophagus with intestinal metaplasia: 5.0 years, indefinite changes for dysplasia: 19.3 years and low-grade dysplasia: 30.0 years. One tenth of patients had developed high-grade dysplasia at 9.6 years and one tenth had developed adenocarcinoma at 13.8 years from symptom onset.
CONCLUSIONS: In patients with columnar-lined oesophagus, symptoms of dysphagia/odynophagia and nausea/vomiting were associated with a higher risk of development of dysplasia and adenocarcinoma. There is a trend for longer duration of symptoms to the detection of dysplasia.

Entities:  

Mesh:

Year:  2009        PMID: 19222408     DOI: 10.1111/j.1365-2036.2009.03969.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  3 in total

Review 1.  Natural history of Barrett's esophagus.

Authors:  Rao Milind; Stephen E Attwood
Journal:  World J Gastroenterol       Date:  2012-07-21       Impact factor: 5.742

2.  Lifetime risk of esophageal adenocarcinoma in patients with Barrett's esophagus.

Authors:  Piers Gatenby; Christine Caygill; Christine Wall; Santanu Bhatacharjee; James Ramus; Anthony Watson; Marc Winslet
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

3.  The minimal incubation period from the onset of Barrett's oesophagus to symptomatic adenocarcinoma.

Authors:  C M den Hoed; M van Blankenstein; J Dees; E J Kuipers
Journal:  Br J Cancer       Date:  2011-06-14       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.